ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies (IPA) is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific program- platforms that blend seamlessly with IPA’s Artemis Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional algorithmic outputs in therapeutic optimization, stability, affinity and manufacturability.

Driving efficiency for drug discovery — by turning complex data into a personalized medicine machine.
LENSai Complex Intelligence Technology builds on IPA’s reputation of scientific excellence, with a totally new approach to biological intelligence.

HYFTs™ System Thinking enables a multi-omics lens for the rapid exploration, interrogation and correlation of vast pools of NEW and EXISTING sources of biological data. This effectively bridges the gap between genomic data and the ability to make it useful—with meaningful specificity for personalized medicine.